ANCER
Live / Registered — Registered (as of 25 Feb 2020)
What this means for you
Registered since 25 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87982539
- Registration number
- 5997775
- Mark type
- Stylized text
- Filed
- 09 Jan 2017
- Published for opposition
- 28 Nov 2017
- Registered
- 25 Feb 2020
- Attorney of record
- Cheryl A. Clarkin
Goods and services
- Class 009 — Scientific and electric apparatus: Computer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines
- Class 042 — Scientific and technological services: Research, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines
- Class 044 — Medical, beauty and agricultural services: Medical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment
Owner
- EPIVAX THERAPEUTICS, INC., PROVIDENCE, RI, US
- EPIVAX ONCOLOGY, INC., Providence, RI, US
- EPIVAX ONCOLOGY, INC., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
Prosecution history
- 25 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Mar 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jan 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Dec 2019 — USE AMENDMENT FILED
- 09 Jan 2020 — DIVISIONAL PROCESSING COMPLETE
- 10 Dec 2019 — DIVISIONAL REQUEST RECEIVED
- 09 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 10 Dec 2019 — TEAS REQUEST TO DIVIDE RECEIVED